• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

143
21
15
12
4

COUNTRY

7
4
4
3
3

PRICE

51
83
103
200

PUBLISHED

3
4
19
200

PRODUCT TYPE

183
14
3

Drug Discovery

Bringing a new medicine to market is a process that cost about $1bn and can take up to 15 years. With the pharmaceutical industry facing multiple crises, budgets for research being squeezed and tough scientific challenges looming, academics and patients' groups are concerned we will not have the drugs necessary to treat future ills. More challenges will be posed by the imminent expiry of patents for some of the most lucrative drugs. The old model of drug discovery seems to be no longer efficient.

What is the future scenario of R&D? Keep track of the latest developments, trends and issues in this crucial sector of the huge pharmaceuticals industry with the publications listed under Research and Markets’ Drug Discovery category. You will find a wide range of academic and scientific textbooks on the latest R&D techniques, as well as top quality market reports with historical data and forecasts. Show Less
Read more

PRODUCT TITLE
Accelerating Lead Generation: Emerging Technologies and Strategies Accelerating Lead Generation: Emerging Technologies and Strategies - Product Thumbnail Image

Accelerating Lead Generation: Emerging Technologies and Strategies

The number of approvals for new drugs and biologics has fallen steadily in recent years, despite increasing R&D expenditure Cost effective and innovative approaches to drug discovery and development...

June 2009
FROM

Pharmacogenomics for Clinical Use and in Drug Development

Pharmacogenomics, the science of individualizing drug therapy based on the genetic makeup of individual patients, offers an unusual opportunity for future market growth Applying pharmacogenomics would...

June 2009
FROM
Competitor Analysis: Plk-1 Inhibitors Competitor Analysis: Plk-1 Inhibitors - Product Thumbnail Image

Competitor Analysis: Plk-1 Inhibitors

The present Competitive Intelligence Report about Plk-1 Inhibitors provides a competitor evaluation in the field of synthetic molecules targeting the polo-like kinase 1 for treatment of cancer as of...

May 2009
FROM
Competitor Analysis: Raf Inhibitors Competitor Analysis: Raf Inhibitors - Product Thumbnail Image

Competitor Analysis: Raf Inhibitors

The present Competitive Intelligence Report about Raf inhibitors provides a competitor evaluation in the field of synthetic molecules targeting Raf and mutant Raf (V600E) for treatment of cancer as...

May 2009
FROM
The Top 20 Contract Research Organisations In Eastern Europe The Top 20 Contract Research Organisations In Eastern Europe - Product Thumbnail Image

The Top 20 Contract Research Organisations In Eastern Europe

The CRO industry in Eastern Europe is predicted to experience double-digit growth over the next five years due to both growth in drug development and the increasing use of outsourcing by pharmaceutical,...

April 2009
FROM
The Top 25 Contract Research Organisations In Germany & France The Top 25 Contract Research Organisations In Germany & France - Product Thumbnail Image

The Top 25 Contract Research Organisations In Germany & France

The CRO industry in Europe is predicted to experience double-digit growth over the next five years due to both growth in drug development and the increasing use of outsourcing by pharmaceutical, biotechnology...

April 2009
FROM
The Top 20 Contract Research Organisations In The United Kingdom The Top 20 Contract Research Organisations In The United Kingdom - Product Thumbnail Image

The Top 20 Contract Research Organisations In The United Kingdom

The CRO industry in Europe is predicted to experience double-digit growth over the next five years due to both growth in drug development and the increasing use of outsourcing by pharmaceutical, biotechnology...

April 2009
FROM
The Top 50 Contract Research Organisations In Europe For Cardiovascular Diseases & Disorders The Top 50 Contract Research Organisations In Europe For Cardiovascular Diseases & Disorders - Product Thumbnail Image

The Top 50 Contract Research Organisations In Europe For Cardiovascular Diseases & Disorders

The CRO industry in Europe is predicted to experience double-digit growth over the next five years due to both growth in drug development and the increasing use of outsourcing by pharmaceutical, biotechnology...

April 2009
FROM
The Top 20 Contract Research Organisations In Europe For Ophthalmic Diseases & Disorders The Top 20 Contract Research Organisations In Europe For Ophthalmic Diseases & Disorders - Product Thumbnail Image

The Top 20 Contract Research Organisations In Europe For Ophthalmic Diseases & Disorders

The CRO industry in Europe is predicted to experience double-digit growth over the next five years due to both growth in drug development and the increasing use of outsourcing by pharmaceutical, biotechnology...

April 2009
FROM
The Top 100 Contract Research Organisations In Europe The Top 100 Contract Research Organisations In Europe - Product Thumbnail Image

The Top 100 Contract Research Organisations In Europe

The CRO industry in Europe is predicted to experience double-digit growth over the next five years due to both growth in drug development and the increasing use of outsourcing by pharmaceutical, biotechnology...

April 2009
FROM
Early Stage Drug Safety Strategies and Risk Management: Maximizing Opportunities Towards Achieving Clinical Success Early Stage Drug Safety Strategies and Risk Management: Maximizing Opportunities Towards Achieving Clinical Success - Product Thumbnail Image

Early Stage Drug Safety Strategies and Risk Management: Maximizing Opportunities Towards Achieving Clinical Success

Declining industrial productivity has forced companies to urgently address the areas of drug development that are most likely to lead to the failure of a new compound Innovations are required that can...

April 2009
FROM
Strategic Analysis of Optical Imaging Technologies in U.S. Clinical Diagnostics and Drug Discovery Markets Strategic Analysis of Optical Imaging Technologies in U.S. Clinical Diagnostics and Drug Discovery Markets - Product Thumbnail Image

Strategic Analysis of Optical Imaging Technologies in U.S. Clinical Diagnostics and Drug Discovery Markets

This research service analyzes optical technologies within the United States clinical imaging and drug discovery markets The market is further divided into seven distinct sub-segments Each segment covers...

March 2009
FROM
The Top 10 Contract Research Organizations: Positioning, Performance and SWOT Analyses The Top 10 Contract Research Organizations: Positioning, Performance and SWOT Analyses - Product Thumbnail Image

The Top 10 Contract Research Organizations: Positioning, Performance and SWOT Analyses

Cost containment and regulatory pressures within the pharma industry are driving R&D outsourcing across the globe Clinical obstacles to approval have become more significant due to the growing availability...

March 2009
FROM
The Future of Biobanks: Regulation, Ethics, Investment and the Humanization of Drug Discovery The Future of Biobanks: Regulation, Ethics, Investment and the Humanization of Drug Discovery - Product Thumbnail Image

The Future of Biobanks: Regulation, Ethics, Investment and the Humanization of Drug Discovery

Biobanks collect and store human biospecimens, playing a vital role in the development of novel drugs and diagnostics In recent years, large population-based biobanks have been established which monitor...

March 2009
FROM
Key Trends in Offshoring Pharmaceutical R&D: Company Strategies, Emerging Markets and Impact on ROI Key Trends in Offshoring Pharmaceutical R&D: Company Strategies, Emerging Markets and Impact on ROI - Product Thumbnail Image

Key Trends in Offshoring Pharmaceutical R&D: Company Strategies, Emerging Markets and Impact on ROI

Offshoring and outsourcing have become an increasingly critical contributor to pharma and biotech R&D strategies in recent years They enable companies to focus on core competencies such as drug discovery...

March 2009
FROM
Drug Registration In China-An overview of China Drug Registration Procedures 2009 Drug Registration In China-An overview of China Drug Registration Procedures 2009 - Product Thumbnail Image

Drug Registration In China-An overview of China Drug Registration Procedures 2009

China is expected to be the fourth largest pharmaceutical market by 2010 as the average annual growth rate of China market has been above 15% since 1978 In 2008, the total pharmaceutical market size...

February 2009
Disease and Therapy Review: High Cholesterol Disease and Therapy Review: High Cholesterol - Product Thumbnail Image

Disease and Therapy Review: High Cholesterol

The High Cholesterol Disease and Therapy Review provides prevalence numbers and percentages for major countries worldwide, information on risk categories, and an overview of treatments, including niacin,...

January 2009
FROM
Competitor Analysis: CD20 Antibodies Competitor Analysis: CD20 Antibodies - Product Thumbnail Image

Competitor Analysis: CD20 Antibodies

The present Competitive Intelligence Report about anti-CD20 antibodies used to treat B-cell mediated malignancies and rheumatoid arthritis provides a competitor evaluation in the field of R&D projects...

January 2009
FROM

Frontiers in Drug Design & Discovery Volume 4

“Frontiers in Drug Design and Discovery” is an Ebook series devoted to publishing the latest and the most important advances in drug design and discovery. Eminent scientists write contributions on all...

January 2009
Overview of the European Drug Discovery Market Overview of the European Drug Discovery Market - Product Thumbnail Image

Overview of the European Drug Discovery Market

This Frost & Sullivan research service titled Overview of the European Drug Discovery Market provides an overview of the drug discovery market together with the revenues generated in western Europe...

December 2008
FROM
Loading Indicator

Our Clients

Our clients' logos